![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 60,335 | 08:00:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/10/2020 18:12 | 150p pmsl. No chance mate | ![]() jambam | |
14/10/2020 18:11 | Skimmed through the RNS and couldnt find details of how much existing shareholders can subscribe for Can anyone help? many thanks G2 x | ![]() geheimnis2 | |
14/10/2020 18:05 | It “may”fal 😂🤣 | ![]() judijudi | |
14/10/2020 18:05 | 150p revised buy order | jock3636 | |
14/10/2020 17:55 | what good news .... phase 111 and 100k doses a month, it may fall but it becomes a buy. | ![]() kcowe | |
14/10/2020 17:55 | Is the open offer ratio shown in the RNS? Is the ex-entitlement date shown in the RNS? If not, why not? I make the open offer something like 4 for 150 at 175p. Is that correct? Surely not? If so it's a pathetic token gesture to meet preemption requirements. | ![]() typo56 | |
14/10/2020 17:54 | Oh yes will be taking my full allocation of my gift shares at 175p! 20 countries and 900 patients will be filled real quick. Following a positive pre-Investigational New Drug (IND) Application meeting with the U.S. Food and Drug Administration (FDA) regarding the design of a Phase III randomised placebo-controlled trial of SNG001 in hospitalised COVID-19 patients, and with manufacturing scale-up activity underway, the Company is pleased to announce the proposed Fundraising of up to £87.0 million to support the Phase III clinical development and supply chain scale-up of SNG001 for COVID-19 patients. | oranolio | |
14/10/2020 17:53 | 17:32 RNS on placing - lol! let mates get in, PI's done over short from 08:00 | ![]() jusjusjus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions